White Paper: Enabling Real-Time Clinical Trials With Centralized Imaging Data Management

Real-time clinical trials (RTCT) are becoming a reality. As the FDA and U.S. Department of Health and Human Services (HHS) work to accelerate drug development through pilot programs that report endpoints and data signals in near real time, biopharma companies will soon be expected to follow suit.

However, processing and managing imaging data in near real time presents a significant hurdle. Between the complexity of imaging files, the fragmented nature of data collection and shifting regulatory requirements, biopharma companies, CROs and other affiliated third parties need a plan of attack to make clinical trial imaging data instantly readable by regulators without breaking data privacy and governance mandates.

In this white paper, we’ll explore how biopharma companies can prepare for RTCT, meeting emerging data mandates while accelerating safe paths to market.